Thomas Dörner

45PUBLICATIONS
174CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursOther biomedical and clinical sciences not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 27, 2026
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

|Nov 10, 2025
Distinct autoreactive CD19- plasma cell subsets accumulate in lupus-prone mice.

Van Duc Dang, Franziska Szelinski, Elodie Mohr

|Jun 29, 2025
Distinct expression of CD56 and CD19 marks molecular and functional endotypes of tetanus- versus RBD-specific human bone marrow plasma cells.

Yidan Chen, Franziska Szelinski, Marta Ferreira-Gomes

|Jun 10, 2025
2023 International Rome consensus for the nomenclature of Sjögren disease.

Manuel Ramos-Casals, Alan N Baer, María Del Pilar Brito-Zerón

|Nov 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study.

Thomas Dörner, Simon J Bowman, Robert Fox

|Nov 07, 2024
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus.

Thomas Dörner, Peter E Lipsky

Pageof 8

Frequent Collaborators

16 joint publications

Martin Aringer

8 joint publications

Yoshiya Tanaka

7 joint publications

Sindhu R Johnson

5 joint publications

Andrea Doria